Miriam P. Rosin

Miriam P. Rosin

Auto-generated profile, based on publicly available information

Miriam P. Rosin

BC Oral Cancer Prevention Program, BC Cancer Agency, Vancouver, BC V5Z 1L3, Canada; School of Biomedical Physiology and Kinesiology, Simon Fraser University, Burnaby, BC V5A 1S6, Canada

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2012 in Cancer Prevention Research
Verified
Journal Article
Open access
PDF file
LZLewei Zhang
Lewei Zhang
CPCatherine F. Poh
Catherine F. Poh
MWMichele Williams
Michele Williams
DLDenise Laronde
Denise Laronde
KBKen Berean
Ken Berean
MRMiriam P. Rosin
Miriam P. Rosin
A major barrier to oral cancer prevention has been the lack of validated risk predictors for oral premalignant lesions (OPL). In 2000, we proposed a loss of heterozygosity (LOH) risk model in a retrospective study. This paper validated the previously reported LOH profiles as risk predictors and developed refined models via the largest longitudinal study to date of low-grade OPLs from a population-based patient group. Analysis involved a prospective cohort of 296 patients with primary mild/moderate oral dysplasia enrolled in the Oral Cancer Prediction Longitudinal Study. LOH status was determined in these OPLs. Patients were classified into high-risk or low-risk profiles to validate the 2000 model. Risk models were refined using recursive partitioning and Cox regression analyses. The prospective cohort validated that the high-risk lesions (3p and/or 9p LOH) had a 22.6-fold increase in risk (P = 0.002) compared with low-risk lesions (3p and 9p retention). Addition of another 2 markers (loci on 4q/17p) further improved the risk prediction, with five-year progression rates of 3.1%, 16.3%, and 63.1% for the low-, intermediate-, and high-risk lesions, respectively. Compared with the low-risk group, intermediate- and high-risk groups had 11.6-fold and 52.1-fold increase in risk (P < 0.001). LOH profiles as risk predictors in the refined model were validated in the retrospective cohort. Multicovariate analysis with clinical features showed LOH models to be the most significant predictors of progression. LOH profiles can reliably differentiate progression risk for OPLs. Potential uses include increasing surveillance for patients with elevated risk, improving target intervention for high-risk patients while sparing a large number of low-risk patients from needless screening and treatment. Cancer Prev Res; 5(9); 1081–9. ©2012 AACR.

24 March 2010 in Cancer
Verified
Journal Article
Open access
PDF file
AAAjit Auluck
Ajit Auluck
GHGreg Hislop
Greg Hislop
CBChris Bajdik
Chris Bajdik
CPCatherine Poh
Catherine Poh
LZLewei Zhang
Lewei Zhang
MRMiriam Rosin
Miriam Rosin
BACKGROUND: There is a growing recognition of the involvement of human papilloma virus infection in the etiology of head and neck cancers at some sites, mainly the base of the tongue, tonsils, and other oropharynx (hereafter termed oropharyngeal cancer). Other oral sites (hereafter termed oral cavity cancer [OCC]) show a stronger association with tobacco and alcohol. Little is known about the ethnic variation in incidence for these cancers. This study determined incidence rates of OCC and oropharyngeal cancer among South Asian, Chinese, and the general population in British Columbia, Canada.METHODS: Patients with OCC and oropharyngeal cancer diagnosed from 1980 to 2006 were identified through the British Columbia cancer registry, and surname lists were used to establish ethnicity. Age‐adjusted incidence rates were determined for these cancers by sex, topographical site, and ethnicity, and temporal trends were examined.RESULTS: Age‐adjusted incidence rates have been decreasing for OCC and increasing for oropharyngeal cancer in the general population for both sexes, with men having higher incidence rates than women. Ethnic differences were found, with the highest age‐adjusted incidence rates for OCC for men in South Asians and for women in Chinese, and with the highest age‐adjusted incidence rates for oropharyngeal cancer for men in Chinese and for women in the general population. Differences were also found for OCC topographical sites by sex and ethnicity.CONCLUSIONS: The incidence of oropharyngeal cancer has now surpassed OCC in the British Columbia male population. Ethnic minorities are at higher risk than the general population for both OCC and oropharyngeal cancer for men, and for OCC for women. Cancer 2010. © 2010 American Cancer Society.

1 September 2016 in Oral Oncology
Verified
Journal Article
Closed access
LZLewei Zhang
Lewei Zhang
TLTarinee Lubpairee
Tarinee Lubpairee
DLDenise Laronde
Denise Laronde
MRMiriam P. Rosin
Miriam P. Rosin

28 September 2012 in Cancer Causes & Control
Verified
Journal Article
Closed access
PDF file
AAAjit Auluck
Ajit Auluck
GHGreg Hislop
Greg Hislop
CBChris Bajdik
Chris Bajdik
JHJohn Hay
John Hay
JBJoan L. Bottorff
Joan L. Bottorff
MRMiriam P. Rosin
Miriam P. Rosin

16 September 2014 in Oral Oncology
Verified
Journal Article
Closed access
VMVictor Martinez
Victor Martinez
CMCalum MacAulay
Calum MacAulay
Martial GuillaudMartial Guillaud
Martial Guillaud
WLWan L. Lam
Wan L. Lam
LZLewei Zhang
Lewei Zhang
MRMiriam P. Rosin
Miriam P. Rosin

1 December 2021 in Cancer Prevention Research
Verified
Journal Article
Closed access
PDF file
MDMadhurima Datta
Madhurima Datta
DLDenise Laronde
Denise Laronde
MRMiriam P. Rosin
Miriam P. Rosin
LZLewei Zhang
Lewei Zhang
BCBertrand Chan
Bertrand Chan
Martial GuillaudMartial Guillaud
Martial Guillaud
Most oral cancers arise from oral potentially malignant lesions, which show varying grades of dysplasia. Risk of progression increases with increasing grade of dysplasia; however, risk prediction among oral low-grade dysplasia (LGD), that is, mild and moderate dysplasia can be challenging as only 5%–15% transform. Moreover, grading of dysplasia is subjective and varies with the area of the lesion being biopsied. To date, no biomarkers or tools are used clinically to triage oral LGDs. This study uses a combination of DNA ploidy and chromatin organization (CO) scores from cells obtained from lesion brushings to identify oral LGDs at high-risk of progression. A total of 130 lesion brushings from patients with oral LGDs were selected of which 16 (12.3%) lesions progressed to severe dysplasia or cancer. DNA ploidy and CO scores were analyzed from nuclear features measured by our in-house DNA image cytometry (DNA-ICM) system and used to classify brushings into low-risk and high-risk. A total of 57 samples were classified as high-risk of which 13 were progressors. High-risk DNA brushing was significant for progression (P = 0.001) and grade of dysplasia (P = 0.004). Multivariate analysis showed high-risk DNA brushing showed 5.1- to 8-fold increased risk of progression, a stronger predictor than dysplasia grading and lesion clinical features. DNA-ICM can serve as a non-invasive, high-throughput tool to identify high-risk lesions several years before transformation. This will help clinicians focus on such lesions whereas low-risk lesions may be spared from unnecessary biopsies. Prevention Relevance: DNA ploidy and chromatin organization of cells collected from oral potentially malignant lesions (OPMLs) can identify lesions at high-risk of progression several years prior. This non-invasive test would enable clinicians to triage high-risk (OPMLs) for closer follow-up while low-risk lesions can undergo less frequent biopsies reducing burden on healthcare resources.